The general treatments include rest, drinking enough water, close observation of the patients’ conditions, antifebrile treatment for patients with high fever.

For patients with mild clinical symptoms without complications in self-limited conditions, positive therapy of neuraminidase inhibitors is not necessary. For patients with severe conditions and dynamic deteriorating conditions as well as population at high risk of infecting Influenza A (H1N1), the therapy of neuraminidase inhibitors should be timely applied as an antiviral therapy.